Takeda Pharmaceutical Company Limited Stock NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.66 USD | +4.42% |
|
+6.49% | +6.90% |
| 05:42pm | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| 01:04pm | Takeda, Insilico Sign AI-Driven Drug Discovery Pact | MT |
| Market Cap | 8,332B 51.79B 45.25B 41.55B 38.75B 73.46B 4,930B 74.7B 500B 194B 2,418B 194B 190B | P/E 2027 * |
41.9x | P/E 2028 * | 26.8x |
|---|---|---|---|---|---|
| Enterprise Value | 12,218B 75.94B 66.35B 60.93B 56.82B 108B 7,229B 110B 734B 284B 3,546B 285B 279B | EV / Sales 2027 * |
2.64x | EV / Sales 2028 * | 2.57x |
| Free-Float |
99.25% | Yield 2027 * |
3.97% | Yield 2028 * | 4.04% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +4.48% | ||
| 1 week | +6.49% | ||
| Current month | +3.96% | ||
| 1 month | +9.78% | ||
| 3 months | -11.07% | ||
| 6 months | +6.69% | ||
| Current year | +6.90% |
| 1 week | 15.72 |  | 16.77 |
| 1 month | 14.84 | | 16.77 |
| Current year | 14.84 | | 18.9 |
| 1 year | 12.99 | | 18.9 |
| 3 years | 12.58 | | 18.9 |
| 5 years | 12.28 | | 18.9 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 24/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.42% | +6.49% | - | - | 50.1B | |
| +1.33% | +7.13% | +55.03% | +161.83% | 1,063B | |
| +2.80% | +6.53% | +67.69% | +59.69% | 611B | |
| +3.58% | +6.73% | +36.05% | +92.22% | 444B | |
| +4.17% | -0.96% | +26.12% | +20.22% | 324B | |
| +4.94% | +3.39% | +39.92% | +40.14% | 285B | |
| +2.42% | +1.60% | +30.06% | +44.59% | 283B | |
| +2.47% | +5.18% | -24.80% | -38.67% | 219B | |
| +3.01% | +5.39% | +25.26% | +65.25% | 195B | |
| +3.48% | +5.26% | +16.90% | +69.91% | 156B | |
| Average | +3.32% | +2.83% | +30.25% | +57.24% | 397.85B | |
| Weighted average by Cap. | +2.81% | +4.16% | +40.88% | +82.45% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.78B 25.15B 23.09B 21.53B 40.82B 2,740B 41.51B 278B 108B 1,344B 108B 106B | 4,701B 29.22B 25.53B 23.44B 21.86B 41.44B 2,781B 42.14B 282B 109B 1,364B 110B 107B |
| Net income | 184B 1.14B 999M 917M 855M 1.62B 109B 1.65B 11.04B 4.28B 53.37B 4.29B 4.2B | 309B 1.92B 1.68B 1.54B 1.44B 2.73B 183B 2.77B 18.57B 7.2B 89.76B 7.22B 7.06B |
| Net Debt | 3,886B 24.15B 21.1B 19.38B 18.07B 34.26B 2,299B 34.84B 233B 90.42B 1,128B 90.68B 88.71B | 3,750B 23.31B 20.37B 18.7B 17.44B 33.07B 2,219B 33.62B 225B 87.27B 1,088B 87.52B 85.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $16.67 | +4.48% | 1,577,611 |
| 01/07/26 | $15.95 | -0.50% | 2,169,571 |
| 30/06/26 | $16.03 | +0.31% | 2,948,737 |
| 29/06/26 | $15.98 | +0.44% | 3,657,878 |
| 26/06/26 | $15.91 | +1.66% | 2,766,432 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Select your edition
All financial news and data tailored to specific country editions
